(Q38500756)

English

Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV-seropositive recipients and donors

scientific article published on August 2008

In more languages
default for all languages
No label defined

No description defined

Statements

Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV-seropositive recipients and donors (English)
Hyeoung-Joon Kim

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit